Actimed Therapeutics
Clinical stage specialty pharmaceutical company
Actimed Therapeutics has raised €5.7M across 1 funding round from 1 investor, most recently a Seed round in Jan 2023. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKactimedtherapeutics.com ↗
Total raised
€5.7M
€5,676,915
Funding rounds
1
Investors
1
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearActimed Therapeutics — funding by year — interactive chart.
Data table
| Actimed Therapeutics — funding by year | |
|---|---|
| 2023 | €5.7M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-04 | Seed | €5.7M | Mankind Pharma | View deal → |
Investors
1Related news
- Indian investor backs £5M seed funding of UK-based pharmatech treating cancer cachexiatechfundingnews.com · 2023-01
Similar companies
same sector or countryGlobal coverage: FundingData